Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 81 entries
Sorted by: Best Match Show Resources per page
Does long-term creatine supplementation impair kidney function in resistance-trained individuals consuming a high-protein diet?.

Journal of the International Society of Sports Nutrition

Lugaresi R, Leme M, de Salles Painelli V, Murai IH, Roschel H, Sapienza MT, Lancha Junior AH, Gualano B.
PMID: 23680457
J Int Soc Sports Nutr. 2013 May 16;10(1):26. doi: 10.1186/1550-2783-10-26.

BACKGROUND: The aim of this study was to determine the effects of creatine supplementation on kidney function in resistance-trained individuals ingesting a high-protein diet.METHODS: A randomized, double-blind, placebo-controlled trial was performed. The participants were randomly allocated to receive either...

Cite
Lugaresi R, Leme M, de Salles Painelli V, et al. Does long-term creatine supplementation impair kidney function in resistance-trained individuals consuming a high-protein diet?. J Int Soc Sports Nutr. 2013;10(1):26doi: 10.1186/1550-2783-10-26.
Lugaresi, R., Leme, M., de Salles Painelli, V., Murai, I. H., Roschel, H., Sapienza, M. T., Lancha Junior, A. H., & Gualano, B. (2013). Does long-term creatine supplementation impair kidney function in resistance-trained individuals consuming a high-protein diet?. Journal of the International Society of Sports Nutrition, 10(1), 26. https://doi.org/10.1186/1550-2783-10-26
Lugaresi, Rebeca, et al. "Does long-term creatine supplementation impair kidney function in resistance-trained individuals consuming a high-protein diet?." Journal of the International Society of Sports Nutrition vol. 10,1 (2013): 26. doi: https://doi.org/10.1186/1550-2783-10-26
Lugaresi R, Leme M, de Salles Painelli V, Murai IH, Roschel H, Sapienza MT, Lancha Junior AH, Gualano B. Does long-term creatine supplementation impair kidney function in resistance-trained individuals consuming a high-protein diet?. J Int Soc Sports Nutr. 2013 May 16;10(1):26. doi: 10.1186/1550-2783-10-26. PMID: 23680457; PMCID: PMC3661339.
Copy Download .nbib Format: NLM
Back to the Future of Soil Metagenomics.

Frontiers in microbiology

Nesme J, Achouak W, Agathos SN, Bailey M, Baldrian P, Brunel D, Frostegård Å, Heulin T, Jansson JK, Jurkevitch E, Kruus KL, Kowalchuk GA, Lagares A, Lappin-Scott HM, Lemanceau P, Le Paslier D, Mandic-Mulec I, Murrell JC, Myrold DD, Nalin R, Nannipieri P, Neufeld JD, O'Gara F, Parnell JJ, Pühler A, Pylro V, Ramos JL, Roesch LF, Schloter M, Schleper C, Sczyrba A, Sessitsch A, Sjöling S, Sørensen J, Sørensen SJ, Tebbe CC, Topp E, Tsiamis G, van Elsas JD, van Keulen G, Widmer F, Wagner M, Zhang T, Zhang X, Zhao L, Zhu YG, Vogel TM, Simonet P.
PMID: 26903960
Front Microbiol. 2016 Feb 10;7:73. doi: 10.3389/fmicb.2016.00073. eCollection 2016.

No abstract available.

Cite
Nesme J, Achouak W, Agathos SN, et al. Back to the Future of Soil Metagenomics. Front Microbiol. 2016;7:73doi: 10.3389/fmicb.2016.00073.
Nesme, J., Achouak, W., Agathos, S. N., Bailey, M., Baldrian, P., Brunel, D., Frostegård, �. �., Heulin, T., Jansson, J. K., Jurkevitch, E., Kruus, K. L., Kowalchuk, G. A., Lagares, A., Lappin-Scott, H. M., Lemanceau, P., Le Paslier, D., Mandic-Mulec, I., Murrell, J. C., Myrold, D. D., Nalin, R., Nannipieri, P., Neufeld, J. D., O'Gara, F., Parnell, J. J., Pühler, A., Pylro, V., Ramos, J. L., Roesch, L. F., Schloter, M., Schleper, C., Sczyrba, A., Sessitsch, A., Sjöling, S., Sørensen, J., Sørensen, S. J., Tebbe, C. C., Topp, E., Tsiamis, G., van Elsas, J. D., van Keulen, G., Widmer, F., Wagner, M., Zhang, T., Zhang, X., Zhao, L., Zhu, Y. G., Vogel, T. M., & Simonet, P. (2016). Back to the Future of Soil Metagenomics. Frontiers in microbiology, 773. https://doi.org/10.3389/fmicb.2016.00073
Nesme, Joseph, et al. "Back to the Future of Soil Metagenomics." Frontiers in microbiology vol. 7 (2016): 73. doi: https://doi.org/10.3389/fmicb.2016.00073
Nesme J, Achouak W, Agathos SN, Bailey M, Baldrian P, Brunel D, Frostegård Å, Heulin T, Jansson JK, Jurkevitch E, Kruus KL, Kowalchuk GA, Lagares A, Lappin-Scott HM, Lemanceau P, Le Paslier D, Mandic-Mulec I, Murrell JC, Myrold DD, Nalin R, Nannipieri P, Neufeld JD, O'Gara F, Parnell JJ, Pühler A, Pylro V, Ramos JL, Roesch LF, Schloter M, Schleper C, Sczyrba A, Sessitsch A, Sjöling S, Sørensen J, Sørensen SJ, Tebbe CC, Topp E, Tsiamis G, van Elsas JD, van Keulen G, Widmer F, Wagner M, Zhang T, Zhang X, Zhao L, Zhu YG, Vogel TM, Simonet P. Back to the Future of Soil Metagenomics. Front Microbiol. 2016 Feb 10;7:73. doi: 10.3389/fmicb.2016.00073. eCollection 2016. PMID: 26903960; PMCID: PMC4748112.
Copy Download .nbib Format: NLM
Haemodynamics during sleep: old results and new perspectives.

Journal of sleep research

Coccagna G, Lugaresi E.
PMID: 10607165
J Sleep Res. 1995 Jun;4:2-7. doi: 10.1111/j.1365-2869.1995.tb00178.x.

After the advent of polygraphic recordings in the 1960s a great deal of interest focused on cardiocirculatory and respiratory activity during sleep. The Bologna sleep laboratory was the first to make direct recordings of systemic arterial pressure, pulmonary arterial...

Cite
Coccagna G, Lugaresi E. Haemodynamics during sleep: old results and new perspectives. J Sleep Res. 1995;4:2-7doi: 10.1111/j.1365-2869.1995.tb00178.x.
Coccagna, G., & Lugaresi, E. (1995). Haemodynamics during sleep: old results and new perspectives. Journal of sleep research, 42-7. https://doi.org/10.1111/j.1365-2869.1995.tb00178.x
Coccagna, and Lugaresi. "Haemodynamics during sleep: old results and new perspectives." Journal of sleep research vol. 4 (1995): 2-7. doi: https://doi.org/10.1111/j.1365-2869.1995.tb00178.x
Coccagna G, Lugaresi E. Haemodynamics during sleep: old results and new perspectives. J Sleep Res. 1995 Jun;4:2-7. doi: 10.1111/j.1365-2869.1995.tb00178.x. PMID: 10607165.
Copy Download .nbib Format: NLM
[Brief considerations on epilepsy during childhood].

La Clinica pediatrica

AMBROSETTO C, LUGARESI E.
PMID: 14012522
Clin Pediatr (Bologna). 1962 Sep;44:567-87.

No abstract available.

Cite
AMBROSETTO C, LUGARESI E. [Brief considerations on epilepsy during childhood]. Clin Pediatr (Bologna). 1962;44:567-87
AMBROSETTO, C., & LUGARESI, E. (1962). [Brief considerations on epilepsy during childhood]. La Clinica pediatrica, 44567-87.
AMBROSETTO, C, and LUGARESI, E. "[Brief considerations on epilepsy during childhood]." La Clinica pediatrica vol. 44 (1962): 567-87.
AMBROSETTO C, LUGARESI E. [Brief considerations on epilepsy during childhood]. Clin Pediatr (Bologna). 1962 Sep;44:567-87. Italian. PMID: 14012522.
Copy Download .nbib Format: NLM
Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis.

Neuropsychiatric disease and treatment

Lugaresi A, di Ioia M, Travaglini D, Pietrolongo E, Pucci E, Onofrj M.
PMID: 23836975
Neuropsychiatr Dis Treat. 2013;9:893-914. doi: 10.2147/NDT.S45144. Epub 2013 Jun 24.

Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system and mainly affects young adults. Its natural history has changed in recent years with the advent of disease-modifying drugs, which have been available since the early...

Cite
Lugaresi A, di Ioia M, Travaglini D, et al. Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis. Neuropsychiatr Dis Treat. 2013;9:893-914doi: 10.2147/NDT.S45144.
Lugaresi, A., di Ioia, M., Travaglini, D., Pietrolongo, E., Pucci, E., & Onofrj, M. (2013). Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis. Neuropsychiatric disease and treatment, 9893-914. https://doi.org/10.2147/NDT.S45144
Lugaresi, Alessandra, et al. "Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis." Neuropsychiatric disease and treatment vol. 9 (2013): 893-914. doi: https://doi.org/10.2147/NDT.S45144
Lugaresi A, di Ioia M, Travaglini D, Pietrolongo E, Pucci E, Onofrj M. Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis. Neuropsychiatr Dis Treat. 2013;9:893-914. doi: 10.2147/NDT.S45144. Epub 2013 Jun 24. PMID: 23836975; PMCID: PMC3699254.
Copy Download .nbib Format: NLM
[A new phase].

Neurocirugia (Asturias, Spain)

Lagares A, Fernández Alén JA, Lobato RD.
PMID: 22520096
Neurocirugia (Astur). 2012 Feb;23(1):1-2. doi: 10.1016/j.neucir.2012.04.001.

No abstract available.

Cite
Lagares A, Fernández Alén JA, Lobato RD. Una nueva etapa. [A new phase]. Neurocirugia (Astur). 2012;23(1):1-2doi: 10.1016/j.neucir.2012.04.001.
Lagares, A., Fernández Alén, J. A., & Lobato, R. D. (2012). Una nueva etapa. [A new phase]. Neurocirugia (Asturias, Spain), 23(1), 1-2. https://doi.org/10.1016/j.neucir.2012.04.001
Lagares, Alfonso, et al. "Una nueva etapa." [A new phase]. Neurocirugia (Asturias, Spain) vol. 23,1 (2012): 1-2. doi: https://doi.org/10.1016/j.neucir.2012.04.001
Lagares A, Fernández Alén JA, Lobato RD. Una nueva etapa. [A new phase]. Neurocirugia (Astur). 2012 Feb;23(1):1-2. doi: 10.1016/j.neucir.2012.04.001. Spanish. PMID: 22520096.
Copy Download .nbib Format: NLM
Normal pressure subdural hygroma with mass effect as a complication of decompressive craniectomy.

Surgical neurology international

Paredes I, Cicuendez M, Delgado MA, Martinez-Pérez R, Munarriz PM, Lagares A.
PMID: 21748040
Surg Neurol Int. 2011;2:88. doi: 10.4103/2152-7806.82370. Epub 2011 Jun 30.

BACKGROUND: Subdural posttraumatic collections are called usually Traumatic Subdural Hygroma (TSH). TSH is an accumulation of cerebrospinal fluid (CSF) in the subdural space after head injury. These collections have also been called Traumatic Subdural Effusion (TSE) or External Hydrocephalous...

Cite
Paredes I, Cicuendez M, Delgado MA, et al. Normal pressure subdural hygroma with mass effect as a complication of decompressive craniectomy. Surg Neurol Int. 2011;2:88doi: 10.4103/2152-7806.82370.
Paredes, I., Cicuendez, M., Delgado, M. A., Martinez-Pérez, R., Munarriz, P. M., & Lagares, A. (2011). Normal pressure subdural hygroma with mass effect as a complication of decompressive craniectomy. Surgical neurology international, 288. https://doi.org/10.4103/2152-7806.82370
Paredes, Igor, et al. "Normal pressure subdural hygroma with mass effect as a complication of decompressive craniectomy." Surgical neurology international vol. 2 (2011): 88. doi: https://doi.org/10.4103/2152-7806.82370
Paredes I, Cicuendez M, Delgado MA, Martinez-Pérez R, Munarriz PM, Lagares A. Normal pressure subdural hygroma with mass effect as a complication of decompressive craniectomy. Surg Neurol Int. 2011;2:88. doi: 10.4103/2152-7806.82370. Epub 2011 Jun 30. PMID: 21748040; PMCID: PMC3130440.
Copy Download .nbib Format: NLM
Ligaments disruption: a new perspective in the prognosis of spinal cord injury.

Neural regeneration research

Martinez-Perez R, Jimenez-Roldan L, Lagares A.
PMID: 25206836
Neural Regen Res. 2014 Mar 01;9(5):456-7. doi: 10.4103/1673-5374.130053.

No abstract available.

Cite
Martinez-Perez R, Jimenez-Roldan L, Lagares A. Ligaments disruption: a new perspective in the prognosis of spinal cord injury. Neural Regen Res. 2014;9(5):456-7doi: 10.4103/1673-5374.130053.
Martinez-Perez, R., Jimenez-Roldan, L., & Lagares, A. (2014). Ligaments disruption: a new perspective in the prognosis of spinal cord injury. Neural regeneration research, 9(5), 456-7. https://doi.org/10.4103/1673-5374.130053
Martinez-Perez, Rafael, et al. "Ligaments disruption: a new perspective in the prognosis of spinal cord injury." Neural regeneration research vol. 9,5 (2014): 456-7. doi: https://doi.org/10.4103/1673-5374.130053
Martinez-Perez R, Jimenez-Roldan L, Lagares A. Ligaments disruption: a new perspective in the prognosis of spinal cord injury. Neural Regen Res. 2014 Mar 01;9(5):456-7. doi: 10.4103/1673-5374.130053. PMID: 25206836; PMCID: PMC4153507.
Copy Download .nbib Format: NLM
Acute neurological deterioration as a result of two synchronous hemorrhagic spinal ependymomas.

Surgical neurology international

Martinez-Perez R, Hernandez-Lain A, Paredes I, Munarriz PM, Castaño-Leon AM, Lagares A.
PMID: 22530168
Surg Neurol Int. 2012;3:33. doi: 10.4103/2152-7806.93865. Epub 2012 Mar 14.

BACKGROUND: Ependymomas are the most common intramedullary tumors in adults and are the most common in mid-adult years. The presence of synchronous ependymomas in different sites of the spine is not common and it is even more infrequent to...

Cite
Martinez-Perez R, Hernandez-Lain A, Paredes I, et al. Acute neurological deterioration as a result of two synchronous hemorrhagic spinal ependymomas. Surg Neurol Int. 2012;3:33doi: 10.4103/2152-7806.93865.
Martinez-Perez, R., Hernandez-Lain, A., Paredes, I., Munarriz, P. M., Castaño-Leon, A. M., & Lagares, A. (2012). Acute neurological deterioration as a result of two synchronous hemorrhagic spinal ependymomas. Surgical neurology international, 333. https://doi.org/10.4103/2152-7806.93865
Martinez-Perez, Rafael, et al. "Acute neurological deterioration as a result of two synchronous hemorrhagic spinal ependymomas." Surgical neurology international vol. 3 (2012): 33. doi: https://doi.org/10.4103/2152-7806.93865
Martinez-Perez R, Hernandez-Lain A, Paredes I, Munarriz PM, Castaño-Leon AM, Lagares A. Acute neurological deterioration as a result of two synchronous hemorrhagic spinal ependymomas. Surg Neurol Int. 2012;3:33. doi: 10.4103/2152-7806.93865. Epub 2012 Mar 14. PMID: 22530168; PMCID: PMC3326940.
Copy Download .nbib Format: NLM
Isolation and characterization of alfalfa-nodulating rhizobia present in acidic soils of central argentina and uruguay .

Applied and environmental microbiology

Abarca FM, Aguilar OM, Balague LJ, del Papa MF, Lagares A, Martinez-Drets G, Niehaus K, P hler A, Segundo E, Sowinski SC, Toro N, Wegener C.
PMID: 10103231
Appl Environ Microbiol. 1999 Apr;65(4):1420-7. doi: 10.1128/AEM.65.4.1420-1427.1999.
Free PMC Article

We describe the isolation and characterization of alfalfa-nodulating rhizobia from acid soils of different locations in Central Argentina and Uruguay. A collection of 465 isolates was assembled, and the rhizobia were characterized for acid tolerance. Growth tests revealed the...

Cite
Abarca FM, Aguilar OM, Balague LJ, et al. Isolation and characterization of alfalfa-nodulating rhizobia present in acidic soils of central argentina and uruguay . Appl Environ Microbiol. 1999;65(4):1420-7doi: 10.1128/AEM.65.4.1420-1427.1999.
Abarca, F. M., Aguilar, O. M., Balague, L. J., del Papa MF, Lagares, A., Martinez-Drets, G., Niehaus, K., P hler A, Segundo, E., Sowinski, S. C., Toro, N., & Wegener, C. (1999). Isolation and characterization of alfalfa-nodulating rhizobia present in acidic soils of central argentina and uruguay . Applied and environmental microbiology, 65(4), 1420-7. https://doi.org/10.1128/AEM.65.4.1420-1427.1999
Abarca, et al. "Isolation and characterization of alfalfa-nodulating rhizobia present in acidic soils of central argentina and uruguay ." Applied and environmental microbiology vol. 65,4 (1999): 1420-7. doi: https://doi.org/10.1128/AEM.65.4.1420-1427.1999
Abarca FM, Aguilar OM, Balague LJ, del Papa MF, Lagares A, Martinez-Drets G, Niehaus K, P hler A, Segundo E, Sowinski SC, Toro N, Wegener C. Isolation and characterization of alfalfa-nodulating rhizobia present in acidic soils of central argentina and uruguay . Appl Environ Microbiol. 1999 Apr;65(4):1420-7. doi: 10.1128/AEM.65.4.1420-1427.1999. PMID: 10103231; PMCID: PMC91201.
Copy Download .nbib Format: NLM
Comparative Effectiveness and Cost-Effectiveness of Natalizumab and Fingolimod in Patients with Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis in the United Kingdom.

PharmacoEconomics

Spelman T, Herring WL, Zhang Y, Tempest M, Pearson I, Freudensprung U, Acosta C, Dort T, Hyde R, Havrdova E, Horakova D, Trojano M, De Luca G, Lugaresi A, Izquierdo G, Grammond P, Duquette P, Alroughani R, Pucci E, Granella F, Lechner-Scott J, Sola P, Ferraro D, Grand'Maison F, Terzi M, Rozsa C, Boz C, Hupperts R, Van Pesch V, Oreja-Guevara C, van der Walt A, Jokubaitis VG, Kalincik T, Butzkueven H.
PMID: 34921350
Pharmacoeconomics. 2021 Dec 18; doi: 10.1007/s40273-021-01106-6. Epub 2021 Dec 18.

BACKGROUND: Patients with highly active relapsing-remitting multiple sclerosis inadequately responding to first-line therapies (interferon-based therapies, glatiramer acetate, dimethyl fumarate, and teriflunomide, known collectively as "BRACETD") often switch to natalizumab or fingolimod.OBJECTIVE: The aim was to estimate the comparative effectiveness...

Cite
Spelman T, Herring WL, Zhang Y, et al. Comparative Effectiveness and Cost-Effectiveness of Natalizumab and Fingolimod in Patients with Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis in the United Kingdom. Pharmacoeconomics. 2021;doi: 10.1007/s40273-021-01106-6.
Spelman, T., Herring, W. L., Zhang, Y., Tempest, M., Pearson, I., Freudensprung, U., Acosta, C., Dort, T., Hyde, R., Havrdova, E., Horakova, D., Trojano, M., De Luca, G., Lugaresi, A., Izquierdo, G., Grammond, P., Duquette, P., Alroughani, R., Pucci, E., Granella, F., Lechner-Scott, J., Sola, P., Ferraro, D., Grand'Maison, F., Terzi, M., Rozsa, C., Boz, C., Hupperts, R., Van Pesch, V., Oreja-Guevara, C., van der Walt, A., Jokubaitis, V. G., Kalincik, T., Butzkueven, H. (2021). Comparative Effectiveness and Cost-Effectiveness of Natalizumab and Fingolimod in Patients with Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis in the United Kingdom. PharmacoEconomics, . https://doi.org/10.1007/s40273-021-01106-6
Spelman, Timothy, et al. "Comparative Effectiveness and Cost-Effectiveness of Natalizumab and Fingolimod in Patients with Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis in the United Kingdom." PharmacoEconomics vol. (2021). doi: https://doi.org/10.1007/s40273-021-01106-6
Spelman T, Herring WL, Zhang Y, Tempest M, Pearson I, Freudensprung U, Acosta C, Dort T, Hyde R, Havrdova E, Horakova D, Trojano M, De Luca G, Lugaresi A, Izquierdo G, Grammond P, Duquette P, Alroughani R, Pucci E, Granella F, Lechner-Scott J, Sola P, Ferraro D, Grand'Maison F, Terzi M, Rozsa C, Boz C, Hupperts R, Van Pesch V, Oreja-Guevara C, van der Walt A, Jokubaitis VG, Kalincik T, Butzkueven H. Comparative Effectiveness and Cost-Effectiveness of Natalizumab and Fingolimod in Patients with Inadequate Response to Disease-Modifying Therapies in Relapsing-Remitting Multiple Sclerosis in the United Kingdom. Pharmacoeconomics. 2021 Dec 18; doi: 10.1007/s40273-021-01106-6. Epub 2021 Dec 18. PMID: 34921350.
Copy Download .nbib Format: NLM
Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registry.

European journal of neurology

Butzkueven H, Spelman T, Horakova D, Hughes S, Solaro C, Izquierdo G, Kubala Havrdová E, Grand'Maison F, Prat A, Girard M, Hupperts R, Onofrj M, Lugaresi A, Taylor B, Giovannoni G, Kappos L, Hauser SL, Montalban X, Craveiro L, Freitas R, Model F, Overell J, Muros-Le Rouzic E, Sauter A, Wang Q, Wormser D, Wolinsky JS.
PMID: 33724638
Eur J Neurol. 2021 Mar 16; doi: 10.1111/ene.14824. Epub 2021 Mar 16.

BACKGROUND AND PURPOSE: Reaching Expanded Disability Status Scale (EDSS) ≥7.0 represents the requirement for a wheelchair. Here we (i) assess the effect of ocrelizumab on time to EDSS ≥7.0 over the ORATORIO (NCT01194570) double-blind and extended controlled periods (DBP+ECP),...

Cite
Butzkueven H, Spelman T, Horakova D, et al. Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registry. Eur J Neurol. 2021;doi: 10.1111/ene.14824.
Butzkueven, H., Spelman, T., Horakova, D., Hughes, S., Solaro, C., Izquierdo, G., Kubala Havrdová, E., Grand'Maison, F., Prat, A., Girard, M., Hupperts, R., Onofrj, M., Lugaresi, A., Taylor, B., Giovannoni, G., Kappos, L., Hauser, S. L., Montalban, X., Craveiro, L., Freitas, R., Model, F., Overell, J., Muros-Le Rouzic, E., Sauter, A., Wang, Q., Wormser, D., & Wolinsky, J. S. (2021). Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registry. European journal of neurology, . https://doi.org/10.1111/ene.14824
Butzkueven, Helmut, et al. "Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registry." European journal of neurology vol. (2021). doi: https://doi.org/10.1111/ene.14824
Butzkueven H, Spelman T, Horakova D, Hughes S, Solaro C, Izquierdo G, Kubala Havrdová E, Grand'Maison F, Prat A, Girard M, Hupperts R, Onofrj M, Lugaresi A, Taylor B, Giovannoni G, Kappos L, Hauser SL, Montalban X, Craveiro L, Freitas R, Model F, Overell J, Muros-Le Rouzic E, Sauter A, Wang Q, Wormser D, Wolinsky JS. Risk of requiring a wheelchair in primary progressive multiple sclerosis: Data from the ORATORIO trial and the MSBase registry. Eur J Neurol. 2021 Mar 16; doi: 10.1111/ene.14824. Epub 2021 Mar 16. PMID: 33724638.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 81 entries